HR 8005: Stop Pills That Kill Act

HR 8005 in plain English: This bill increases criminal penalties for illegally manufacturing fentanyl or counterfeit substances and extends existing penalties—currently limited to methamphetamine offenses—to cover fentanyl-related equipment and materials. It requires the DEA to create a plan targeting counterfeit fentanyl and methamphetamine through law enforcement, education, and prevention. The Department of Justice must also submit annual reports on law enforcement collection of these substances and related prosecutions.

Stated purpose

This bill aims to stop the illegal manufacture of fentanyl and counterfeit pills by increasing criminal penalties for misusing pill-making equipment and by requiring federal agencies to take action against counterfeit drug substances.

Key points

• Extends increased criminal penalties for possessing or manufacturing illegal drug equipment to cover fentanyl and counterfeit substances, not just methamphetamine
• Requires the DEA to establish a plan addressing counterfeit fentanyl and methamphetamine through law enforcement, education, and prevention
• Requires the DOJ to submit annual reports on law enforcement seizures of counterfeit fentanyl or methamphetamine and related prosecutions

Arguments supporters make

• Fentanyl and counterfeit pills kill tens of thousands of Americans each year, and tougher penalties on the machines used to make them could deter illegal manufacturing at the source.
• Requiring serial numbers and transaction records for pill-making equipment gives law enforcement a paper trail to track how these machines end up in the hands of drug traffickers.
• Requiring the DEA and DOJ to create plans and annual reports adds accountability and ensures the government is actively measuring progress against the counterfeit pill problem.

Arguments opponents make

• Higher criminal penalties have historically had limited effect on deterring drug trafficking, and critics argue this approach repeats tough-on-crime policies that have not solved the underlying drug crisis.
• Legitimate businesses such as pharmaceutical companies and supplement manufacturers that legally use tableting and encapsulating machines face new regulatory burdens and compliance costs even though they are not the problem.
• The bill focuses on supply-side enforcement but does not address addiction treatment or demand reduction, which some argue are more effective long-term solutions to the fentanyl crisis.

Tradeoffs

Stricter regulation and tracking of pill-making equipment may help disrupt illegal drug manufacturing, but also places new compliance requirements on lawful businesses that use the same equipment for legal purposes. Increased criminal penalties may punish more offenders but do not directly reduce the demand for drugs or expand access to treatment.

Current status in Congress: Passed House.

NewsClear — neutral news & congressional tracking · Bill of the Week